Pneumonia News and Research

Latest Pneumonia News and Research

MRSA bacteria exposed to cigarette smoke become more resistant to antimicrobial peptides

Methicillin-resistant Staphylococcus aureus (MRSA), an antibiotic-resistant superbug, can cause life-threatening skin, bloodstream and surgical site infections or pneumonia. Researchers at the University of California, San Diego School of Medicine now report that cigarette smoke may make matters worse.

3 Apr 2015

Collaboration between nurses and physicians decreases rates of HAIs in critical care

Collaborative relationships between nurses and physicians decrease rates of healthcare-associated infections (HAIs) in critical care, according to an article in the April issue of Critical Care Nurse.

2 Apr 2015

NPS MedicineWise program focuses on optimal use of PPI therapy in GORD patients

NPS MedicineWise today launches a new learning program and health professional tools on the use of proton pump inhibitors (PPIs) in the treatment of uncomplicated gastro-oesophageal reflux disease (GORD).

1 Apr 2015

Patient with severe Alzheimer's shows promising benefits during treatment with Bryostatin drug

Researchers at the Blanchette Rockefeller Neurosciences Institute and the Marshall University Joan C. Edwards School of Medicine announced their findings from a new study entitled, "PSEN1 Variant in a Family with Atypical AD." An Alzheimer patient with very severe disease, genetically confirmed to have a known variant of PSEN1, showed promising benefits during treatment with the drug Bryostatin 1.

30 Mar 2015

Amgen receives FDA priority review designation for Kyprolis to treat relapsed multiple myeloma

Amgen today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) of Kyprolis® (carfilzomib) for Injection for the treatment of patients with relapsed multiple myeloma who have received at least one prior therapy.

30 Mar 2015

Aridis Pharmaceuticals begins Aerucin Phase 1 clinical study for treatment of acute pneumonia

Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel therapies for infectious diseases, announced today the initiation of a Phase 1 clinical study of Aerucin, the Company's fully human IgG1 monoclonal antibody (mAb) against Pseudomonas aeruginosa bacteria, which is being developed as an adjunctive treatment for acute pneumonia.

26 Mar 2015

WHO calls for intensification of routine immunization services in all Ebola-affected areas

A growing risk of outbreaks of measles, pertussis, and other vaccine-preventable diseases in countries affected by Ebola must be countered by urgent scaling up of routine immunization activities, according to the World Health Organization.

21 Mar 2015

GW, Children's National researchers awarded $6.2 million grant to solve pediatric dysphagia

An interdisciplinary group of researchers from the George Washington University School of Medicine and Health Sciences and Children's National Health System has been awarded a program project grant (PPG) for $6.2 million from The Eunice Kennedy Shriver National Institute of Child Health and Human Development to solve pediatric dysphagia -- a chronic difficulty with feeding and swallowing in children.

17 Mar 2015

New UNICEF report highlights urgency of reducing Ebola cases

Ebola has had a devastating impact on children, who make up about 20 per cent of infections in Guinea, Liberia and Sierra Leone. To protect them and their communities, it is critical to defeat this scourge, while working to restore basic services, UNICEF said in a report released today.

17 Mar 2015

Ebola crisis increases susceptibility to measles, other vaccine-preventable illnesses

Johns Hopkins Bloomberg School of Public Health researchers say that major disruptions in the health care systems in West Africa caused by the Ebola crisis have led to significant decreases in vaccinations for childhood diseases, increasing susceptibility to measles and other vaccine-preventable illnesses.

13 Mar 2015

Rehospitalizations after severe sepsis may be potentially preventable

In an analysis of about 2,600 hospitalizations for severe sepsis, readmissions within 90 days were common, and approximately 40 percent occurred for diagnoses that could potentially be prevented or treated early to avoid hospitalization, according to a study in the March 10 issue of JAMA.

12 Mar 2015

Advanced clinical decision support tools reduce mortality for pneumonia patients

A new study by Intermountain Medical Center researchers in Salt Lake City found that using advanced clinical decision support tools reduces mortality for the 1.1 million patients in the Unites States who are treated for pneumonia each year.

11 Mar 2015

Repeatedly exposing children to secondhand smoke is child abuse, argues Adam Goldstein

Purposefully and repeatedly exposing children to secondhand smoke — a known human carcinogen — is child abuse, according to an opinion piece written by Adam Goldstein, MD, MPH, a professor in the Department of Family Medicine at the University of North Carolina School of Medicine.

11 Mar 2015

Somna Therapeutics receives FDA clearance to market REZA BAND UES Assist Device in U.S.

Somna Therapeutics today announced that the U.S. Food and Drug Administration cleared the REZA BAND UES Assist Device for marketing in the U.S. The REZA BAND is a ground-breaking, new, externally-worn, non-medication, non-surgical medical device designed to reduce symptoms of laryngopharyngeal reflux (LPR) by stopping regurgitation of stomach contents through the upper esophageal sphincter (UES).

10 Mar 2015

Advanced clinical decision support tools help reduce mortality for pneumonia patients

10 Mar 2015

Phico Therapeutics gets £2.25M Translation Award to develop SASPject PT4 antibiotic for E. coli, K. pneumoniae

Phico Therapeutics, a biotechnology company developing a novel platform technology for a new generation of antibiotics aimed at overcoming antibacterial resistance, has been awarded a £2.25M Translation Award by the Wellcome Trust to develop its SASPject PT4 antibiotic, aimed at Escherichia coli and Klebsiella pneumoniae.

9 Mar 2015

Life expectancy for Spaniards increases due to 'cardiovascular revolution'

Over the last century, life expectancy for Spaniards has increased by 40 years. A study by the International University of La Rioja highlights the main cause, since 1980, as being the reduced incidence of cardiovascular diseases while other pathologies, such as mental illnesses and certain types of cancer, have been seen to rise. The authors predict that the effects of the economic recession on mortality will show up in the long-term.

4 Mar 2015

Health systems in developing world need to be strengthened to stop Ebola-style outbreak

Health systems throughout the developing world need to be strengthened to prevent another Ebola-style outbreak, or worse, warns Save the Children in its new report "A Wake Up Call: Lessons from Ebola for the World's Health Systems."

3 Mar 2015

Anticholinergic medications associated with pneumonia risk in older people

Taking commonly used medications with anticholinergic effects is associated with a significantly higher risk for developing pneumonia in a study of more than 3,000 older Group Health patients living in the community--not in nursing homes.

3 Mar 2015

Majority of ACS NSQIP hospitals improve surgical outcomes over time

The majority of hospitals participating in the American College of Surgeons National Surgical Quality Improvement Project improve surgical outcomes over time, and improvement continues with each year that hospitals participate in the program, according to a new study published online today in Annals of Surgery.

28 Feb 2015

Pneumonia News and Research

Latest Pneumonia News and Research

MRSA bacteria exposed to cigarette smoke become more resistant to antimicrobial peptides

Collaboration between nurses and physicians decreases rates of HAIs in critical care

NPS MedicineWise program focuses on optimal use of PPI therapy in GORD patients

Patient with severe Alzheimer's shows promising benefits during treatment with Bryostatin drug

Amgen receives FDA priority review designation for Kyprolis to treat relapsed multiple myeloma

Aridis Pharmaceuticals begins Aerucin Phase 1 clinical study for treatment of acute pneumonia

WHO calls for intensification of routine immunization services in all Ebola-affected areas

GW, Children's National researchers awarded $6.2 million grant to solve pediatric dysphagia

New UNICEF report highlights urgency of reducing Ebola cases

Ebola crisis increases susceptibility to measles, other vaccine-preventable illnesses

Rehospitalizations after severe sepsis may be potentially preventable

Advanced clinical decision support tools reduce mortality for pneumonia patients

Repeatedly exposing children to secondhand smoke is child abuse, argues Adam Goldstein

Somna Therapeutics receives FDA clearance to market REZA BAND UES Assist Device in U.S.

Advanced clinical decision support tools help reduce mortality for pneumonia patients

Phico Therapeutics gets £2.25M Translation Award to develop SASPject PT4 antibiotic for E. coli, K. pneumoniae

Life expectancy for Spaniards increases due to 'cardiovascular revolution'

Health systems in developing world need to be strengthened to stop Ebola-style outbreak

Anticholinergic medications associated with pneumonia risk in older people

Majority of ACS NSQIP hospitals improve surgical outcomes over time

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Pneumonia News and Research

Latest Pneumonia News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in